Bibliografía
  1. Kelly Rhodiola rosea: a possible plant adaptogen. Altern Med Rev 2001;6:293–302.
  1. Panossian A,  Wikman. Evidence-based efficacy  of  adaptogens in  fatigue,  and  molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol. 2009 Sep;4(3):198-219. Epub 2009 Sep 1.
  1. Maslova LV, Kondrat’ev BI, Maslov LN, Lishmanov The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress. Eksp Klin Farmakol 1994;57:61-63.
  1. Lishmanov IB, Trifonova ZV, Tsibin AN, et Plasma beta-endorphin and stress hormones in stress and adaptation. Biull Eksp Biol Med 1987;103:422-424.
  1. Lishmanov IB, Maslova LV, Maslov LN, Dan’shina The anti-arrhythmia effect of Rhodiola roseaand its possible mechanism. Biull Eksp Biol Med 1993;116:175-176.
  1. Lishmanov IB, Naumova AV, Afanas’ev SA, Maslov Contribution of the opioid system to realization of inotropic effects of Rhodiola rosea extracts in ischemic and reperfusion heart damagein vitro. Eksp Klin Farmakol 1997;60:34-36.
  1. Maimeskulova LA, Maslov LN, Lishmanov IB, Krasnov The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea. Eksp Klin Farmakol 1997;60:38-39.
  1. Stancheva SL, Mosharrof Effect of the extract of Rhodiola rosea L. on the content of the brain biogenic monamines. Med Physiol 1987;40:85-87.
  1. Brown ,  Gerbarg  PL.  The Rhodiola Revolution:  Transform  Your Breakthrough of the 21st Century. 4th ed. Emmaus, Rodale; 2004. Health  with  the  Herbal
  1. Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner Rhodiola rosea in stress induced fatigue: a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy  physicians during night duty. Phytomedicine 2000;7(5):365-71.
  1. Furmanowa M, Skopinska-Rozewska E, Rogala E, Malgorzata Rhodiola rosea in vitro culture: phytochemical analysis and antioxidant action. Acta Societis Botanicorum Poloniae 1998;76(1):69-73.
  1. Saratikov AS, Krasnov Chapter VII: Adaptogenic properties of Rhodiola rosea. In: Saratikov AS, Krasnov, editors. Rhodiola rosea is a valuable medicinal plant (Golden Root). Tomsk, Russia:Tomsk State University Press; 1987. p. 194-215.
  1. Spasov AA, Mandrikov VB, Mironova The effect of the preparation rhodiosin on the psychophysiological and physical adaptation of students to an academic load. Eksp Klin Farmakol2000;63(1):76-8.
  1. Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin A double-blind, placebo- controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 2000;7(2):85-9.
  1. Petkov VD, Stancheva SL, Tocuschieva L, Petkov Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats). Gen Pharmacol 1990;21(1):71-5.
  1. Baranov Experimental trials of herbal adaptation effect on the quality of the operation activity, mental and professional work capacity. Contract 93-11-615 Stage 2 Phase I. Moscow, Russia: Russian Federation Ministry of Health Institute of Medical ans Biological Problems; 1994.
  1. Komar VV, Kit SM, Sischuk LV, Sischuk Effect of Rhodiola rosea on the  human  mental activity. Pharmaceutical J Gen Pharmacol 1981;36(4):62-4.
  1. Saratikov A, Marina TF, Fisanova Effect of golden root extract on processes of serotonin synthesis in CNS. Journal of Biological Sciences 1978;6:142.
  1. Marina Effect of Rhodiola rosea extract on bioelectrical activity of the cerebral cortex isolated to a different extent from the brain. In. Saratikov AS, editor. Stimulants of the Central Nervous System. Tomsk, Russia: Tomsk State University Press; 1968. p. 27-31.
  2. Brown RP, Gerbarg PL, Muskin Alternative Therapies in Psychiatry. In: Tasman A, Lieberman J, Kay J, editors. Psychiatry. 2nd ed [in press]. West Sussex, England: Wiley & Sons, Ltd.; 2002.
  3. Chen X, Deng A, Zhou T, Ding Pretreatment with 2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy- β-D-pyranoside Attenuates Cerebral Ischemia/Reperfusion-Induced Injury In Vitro and In Vivo. PLoS One. 2014;9(7):e100126.
  4. Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian Clinical trial ofRhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry. 2007;61(5):343-8. Erratum in: Nord J Psychiatry. 2007;61(6):503.
  5. Bystritsky A, Kerwin L, Feusner A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med. 2008 Mar;14(2):175-80.
  6. Zhong X, Lin R, Li Z, Mao J, Chen Effects of Salidroside on cobalt chloride-induced hypoxia damage and mTOR signaling repression in PC12 cells. Biol Pharm Bull. 2014;37(7):1199-206.
  1. Fintelmann V, Gruenwald Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies. Adv Ther. 2007 Jul-Aug;24(4):929-39.
  1. Ross Rhodiola rosea (SHR-5), Part 2: A Standardized Extract of Rhodiola rosea Is Shown to Be Effective in the Treatment of Mild to Moderate Depression. Holist Nurs Pract. 2014 May-June;28(3):217- 221.
  1. Maimeskulova LA, Maslov The anti-arrhythmia action of an extract of Rhodiola rosea and of n- tyrosol in models of experimental arrhythmias. Eksp Klin Farmakol 1998;61:37-40.
  1. Saratikov Golden Root (Rhodiola rosea). Tomsk, Russia: Tomsk State University Press; 1974.
  1. Wang J, Li JZ, Lu AX, Zhang KF, Li Anticancer effect of salidroside on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expression. Oncol Lett. 2014 Apr;7(4):1159-1164.
  1. Zhou Q, Yin ZP, Ma L, Zhao W, Hao HW, Li Free radical-scavenging activities of oligomeric proanthocyanidin  from Rhodiola  rosea L.  and  its  antioxidant  effects  in Dec;28(24):2301-2303. vivo. Nat  Prod  Res.  2014
  1. Wang S, He H, Chen L, Zhang W, Zhang X, Chen J. Protective Effects of Salidroside in the MPTP/MPP+-Induced Model of Parkinson’s Disease through ROS-NO-Related Mitochondrion Pathway.Mol Neurobiol. 2014/06/07:1-11.
  1. Doncheva ND, Mihaylova AS, Getova Antinociceptive and anti-inflammatory effects ofRhodiola rosea L. extract in rats. Folia Med. 2012 Jul-Dec;55(3-4):70-75.
  1. Lee Y1, Jung JC, Jang S, Kim J, Ali Z, Khan IA, Oh Anti-Inflammatory and Neuroprotective Effects of Constituents Isolated from Rhodiola rosea. Evid Based Complement Alternat Med. 2013;2013:514049.
  1. Ross Rhodiola rosea (SHR-5), Part I: a proprietary root extract of Rhodiola rosea is found to be effective in the treatment of stress-related fatigue. Holist Nurs Pract. 2014 Mar-Apr;28(2):149-154.
  1. Shevtsov VA, Zholus BI, Shervarly VI, et A randomized trial of two different doses of a SHR- 5Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine. 2003 Mar;10(2-3):95-105.
  1. De Bock K, Eijnde BO, Ramaekers M, Hespel Acute Rhodiola rosea intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab. 2004 Jun;14(3):298-307.
  1. Olsson EM, von Schéele B, Panossian A randomised, double-blind, placebo-controlled, parallel- group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009 Feb;75(2):105-12. Epub 2008 Nov 18.
  1. Gerbarg PL, Brown RP. Pause menopause with Rhodiola rosea, a natural selective estrogen receptor modulator. Phytomedicine. 2016 Jun 15;23(7):763-9. doi: 10.1016/j.phymed.2015.11.013. Epub 2015 Dec 12.
  1. Cropley M, Banks AP, Boyle J. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. Phytother Res. 2015 Dec;29(12):1934-9. doi: 10.1002/ptr.5486. Epub 2015 Oct 27.
  1. Xing SS et al. Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway. Vascul Pharmacol. 2015 Sep;72:141-52. doi: 10.1016/j.vph.2015.07.004. Epub 2015 Jul 15.
  1. Amsterdam JD, Panossian AG. Rhodiola rosea L. as a putative botanical antidepressant. Phytomedicine. 2016 Jun 15;23(7):770-83. doi: 10.1016/j.phymed.2016.02.009. Epub 2016 Feb 24.
  1. Nabavi SF, Braidy N, Orhan IE, Badiee A, Daglia M, Nabavi SM. Review: Rhodiola rosea L. and Alzheimer’s Disease: From Farm to Pharmacy. Phytother Res. 2016 Apr;30(4):532-9. doi: 10.1002/ptr.5569. Epub 2016 Jan 11.
  1. Radomska-Leśniewska DM et al. Angiomodulatory properties of Rhodiola spp. and other natural antioxidants. Cent Eur J Immunol. 2015;40(2):249-62. doi: 10.5114/ceji.2015.52839. Epub 2015 Aug 3.
  1. Lee Y et al. Anti-Inflammatory and Neuroprotective Effects of Constituents Isolated from Rhodiola rosea. Evid Based Complement Alternat Med. 2013;2013:514049. doi: 10.1155/2013/514049. Epub 2013 Apr 16.
  1. Recio MC, Giner RM, Máñez S. Immunmodulatory and Antiproliferative Properties of Rhodiola Species. Planta Med. 2016 Jul;82(11-12):952-60. doi: 10.1055/s-0042-107254. Epub 2016 May 25.
  1. Déciga-Campos M et al. Antihyperalgesic Activity of Rhodiola rosea in a Diabetic Rat Model. Drug Dev Res. 2016 Feb;77(1):29-36. doi: 10.1002/ddr.21289. Epub 2016 Jan 13.
  1. Alameddine A et al. The cardiovascular effects of salidroside in the Goto-Kakizaki diabetic rat model. J Physiol Pharmacol. 2015 Apr;66(2):249-57.
Su carro